REZUROCK
Live / Registered — Registered (as of 02 Nov 2021)
What this means for you
Registered since 02 Nov 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90071349
- Registration number
- 6548713
- Mark type
- Design + words
- Filed
- 24 Jul 2020
- Published for opposition
- 15 Dec 2020
- Registered
- 02 Nov 2021
- Attorney of record
- Michael J. Leonard
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals and pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical products for the prevention and treatment of respiratory diseases
Owner
- Kadmon Pharmaceuticals, LLC, Warrendale, PA, US
- Kadmon Pharmaceuticals, LLC, Warrendale, PA, US
- Kadmon Pharmaceuticals, LLC, Warrendale, PA, US
Prosecution history
- 02 Nov 2021 — REGISTERED-PRINCIPAL REGISTER
- 29 Sept 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 28 Sept 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Sept 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 02 Sept 2021 — USE AMENDMENT FILED
- 13 Sept 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Sept 2021 — TEAS STATEMENT OF USE RECEIVED
- 11 Aug 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Aug 2021 — SOU EXTENSION 1 GRANTED
- 09 Aug 2021 — SOU EXTENSION 1 FILED
- 09 Aug 2021 — SOU TEAS EXTENSION RECEIVED
- 09 Feb 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Dec 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Dec 2020 — PUBLISHED FOR OPPOSITION
- 25 Nov 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED